Eliana Merle's Stock Ratings

UBS Analyst

Eliana Merle is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

0.70%

Smart Score

50.2%

Overall Average Return Percentile

39th

Number of Ratings

39
Buy NowGet Alert
06/28/2024ALNYBuy Now
Alnylam Pharmaceuticals
$243.0018.52%$253 → $288MaintainsBuyGet Alert
06/20/2024ZNTLBuy Now
Zentalis Pharma
$4.0922.25%$28 → $5DowngradeBuy → NeutralGet Alert
05/28/2024BBIOBuy Now
BridgeBio Pharma
$25.3285.62%$51 → $47MaintainsBuyGet Alert
05/08/2024APLSBuy Now
Apellis Pharmaceuticals
$38.90118.51%$89 → $85MaintainsBuyGet Alert
05/07/2024MRNABuy Now
Moderna
$118.8027.1%$143 → $151MaintainsBuyGet Alert
04/04/2024KODBuy Now
Kodiak Sciences
$2.33114.59%$3 → $5MaintainsNeutralGet Alert
03/27/2024TERNBuy Now
Terns Pharma
$6.91160.49%$19 → $18MaintainsBuyGet Alert
03/27/2024BNTXBuy Now
BioNTech
$81.8923.33%$110 → $101MaintainsNeutralGet Alert
03/15/2024MDGLBuy Now
Madrigal Pharmaceuticals
$278.9047.01%$337 → $410MaintainsBuyGet Alert
03/05/2024AKROBuy Now
Akero Therapeutics
$23.4679.03%$39 → $42MaintainsBuyGet Alert
03/04/2024APLSBuy Now
Apellis Pharmaceuticals
$38.90128.79%$87 → $89MaintainsBuyGet Alert
02/22/2024RAPTBuy Now
RAPT Therapeutics
$3.08224.68%$61 → $10DowngradeBuy → NeutralGet Alert
02/14/2024CBAYBuy Now
CymaBay Therapeutics
——$25 → $32.5DowngradeBuy → NeutralGet Alert
12/21/2023KODBuy Now
Kodiak Sciences
$2.3328.76%$4 → $3MaintainsNeutralGet Alert
12/20/2023RVMDBuy Now
Revolution Medicines
$38.813.07% → $40Initiates → BuyGet Alert
11/02/2023ANABBuy Now
AnaptysBio
$25.06-16.2%$28 → $21MaintainsNeutralGet Alert
10/12/2023ETNBBuy Now
89bio
$8.01212.11%$36 → $25MaintainsBuyGet Alert
10/12/2023AKROBuy Now
Akero Therapeutics
$23.4666.24%$83 → $39MaintainsBuyGet Alert
09/26/2023CBAYBuy Now
CymaBay Therapeutics
——$18 → $25MaintainsBuyGet Alert
08/28/2023ETNBBuy Now
89bio
$8.01349.44% → $36Initiates → BuyGet Alert
08/28/2023AKROBuy Now
Akero Therapeutics
$23.46253.79% → $83Initiates → BuyGet Alert
08/23/2023APLSBuy Now
Apellis Pharmaceuticals
$38.9064.52%$60 → $64MaintainsBuyGet Alert
08/14/2023CBAYBuy Now
CymaBay Therapeutics
—— → $18Initiates → BuyGet Alert
07/27/2023KODBuy Now
Kodiak Sciences
$2.3371.67%$15 → $4DowngradeBuy → NeutralGet Alert
06/26/2023MRNABuy Now
Moderna
$118.8060.77%$221 → $191UpgradeNeutral → BuyGet Alert
05/19/2023QUREBuy Now
uniQure
$4.48837.5%$45 → $42MaintainsBuyGet Alert
05/03/2023ISEEBuy Now
IVERIC bio
——$34 → $40DowngradeBuy → NeutralGet Alert
03/31/2023BNTXBuy Now
BioNTech
$81.8986.83%$168 → $153MaintainsNeutralGet Alert
02/07/2023TERNBuy Now
Terns Pharma
$6.91174.96% → $19Initiates → BuyGet Alert
01/19/2023CVACBuy Now
CureVac
$3.37434.12% → $18UpgradeNeutral → BuyGet Alert
12/21/2022MDGLBuy Now
Madrigal Pharmaceuticals
$278.9020.83%$161 → $337MaintainsBuyGet Alert
12/07/2022GOSSBuy Now
Gossamer Bio
$0.89798.78%$19 → $8MaintainsBuyGet Alert
11/23/2022QUREBuy Now
uniQure
$4.48837.5%$40 → $42MaintainsBuyGet Alert
10/13/2022GLUEBuy Now
Monte Rosa Therapeutics
$3.75486.67% → $22Initiates → BuyGet Alert
08/02/2022ISEEBuy Now
IVERIC bio
—— → $20Initiates → BuyGet Alert
06/23/2022RGNXBuy Now
Regenxbio
$11.50308.7%$51 → $47MaintainsBuyGet Alert
04/06/2022GOSSBuy Now
Gossamer Bio
$0.892034.59% → $19Initiates → BuyGet Alert
03/17/2022QUREBuy Now
uniQure
$4.48792.86% → $40UpgradeNeutral → BuyGet Alert
01/21/2022MRNABuy Now
Moderna
$118.8086.03% → $221Initiates → NeutralGet Alert